Literature DB >> 20388510

The molecular signature of oncofusion proteins in acute myeloid leukemia.

Joost H A Martens1, Henk G Stunnenberg.   

Abstract

Acute myeloid leukemia (AML) associated translocations often cause gene fusions that encode oncofusion proteins. Although many of the breakpoints involved in chromosomal translocations have been cloned, in most cases the role of the chimeric proteins in tumorigenesis is not elucidated. Here we will discuss the fusion proteins of the 4 most common translocations associated with AML as well as the common molecular mechanisms that these four and other fusion proteins utilize to transform progenitor cells. Intriguingly, although the individual partners within the fusion proteins represent a wide variety of cellular functions, at the molecular level many commodities can be found. Copyright 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388510     DOI: 10.1016/j.febslet.2010.04.002

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  38 in total

1.  Adipocyte JAK2 mediates growth hormone-induced hepatic insulin resistance.

Authors:  Kevin C Corbit; João Paulo G Camporez; Jennifer L Tran; Camella G Wilson; Dylan A Lowe; Sarah M Nordstrom; Kirthana Ganeshan; Rachel J Perry; Gerald I Shulman; Michael J Jurczak; Ethan J Weiss
Journal:  JCI Insight       Date:  2017-02-09

2.  Value of multifaced approach diagnosis and classification of acute leukemias.

Authors:  Silvana Angelescu; Nicoleta Mariana Berbec; Andrei Colita; Doina Barbu; Anca Roxana Lupu
Journal:  Maedica (Buchar)       Date:  2012-09

3.  Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.

Authors:  Patrick J Grohar; Girma M Woldemichael; Laurie B Griffin; Arnulfo Mendoza; Qing-Rong Chen; Choh Yeung; Duane G Currier; Sean Davis; Chand Khanna; Javed Khan; James B McMahon; Lee J Helman
Journal:  J Natl Cancer Inst       Date:  2011-06-08       Impact factor: 13.506

Review 4.  Significance of oncogenes and tumor suppressor genes in AML prognosis.

Authors:  Maria Kavianpour; Ahmad Ahmadzadeh; Saeid Shahrabi; Najmaldin Saki
Journal:  Tumour Biol       Date:  2016-05-14

Review 5.  Dynamics of epigenetic modifications in leukemia.

Authors:  Iris Uribesalgo; Luciano Di Croce
Journal:  Brief Funct Genomics       Date:  2011-01-21       Impact factor: 4.241

Review 6.  Molecular mechanisms of leukemia-associated protein degradation.

Authors:  Ying-Li Wu; Hu-Chen Zhou; Guo-Qiang Chen
Journal:  Front Med China       Date:  2010-11-19

7.  Genetic abnormalities and challenges in the treatment of acute myeloid leukemia.

Authors:  C Chandra Kumar
Journal:  Genes Cancer       Date:  2011-02

Review 8.  Polycomb group proteins in hematopoietic stem cell aging and malignancies.

Authors:  Karin Klauke; Gerald de Haan
Journal:  Int J Hematol       Date:  2011-04-27       Impact factor: 2.490

Review 9.  Chromatin remodeling in cancer: a gateway to regulate gene transcription.

Authors:  Sujit S Nair; Rakesh Kumar
Journal:  Mol Oncol       Date:  2012-10-22       Impact factor: 6.603

10.  SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update.

Authors:  Luana Licata; Prisca Lo Surdo; Marta Iannuccelli; Alessandro Palma; Elisa Micarelli; Livia Perfetto; Daniele Peluso; Alberto Calderone; Luisa Castagnoli; Gianni Cesareni
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.